Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  Mitsubishi Tanabe Pharma Corp    4508   JP3469000008

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Manufactures and distributes pharmaceuticals, pet products and medicines

Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products.

Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera.

The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan.

Number of employees : 8 457 persons.
Sales per Businesses
20142015Delta
JPY (in Million)%JPY (in Million)%
Pharmaceuticals412,675100%415,124100% +0.59%
Sales per Regions
20142015Delta
JPY (in Million)%JPY (in Million)%
Japan353,30085.6%337,18081.2% -4.78%
Europe37,3489.1%48,61811.7% +23.18%
Asia15,9773.9%17,2454.2% +7.35%
North America5,6271.4%11,6962.8% +51.89%
Other423.000.1%385.000.1% -9.87%
Managers
NameAgeSinceTitle
Masayuki Mitsuka, PhD622007President & Representative Director
Michihiro Tsuchiya, PhD691976Chairman
Eizou Tabaru--Manager-Finance & Investor Relations Contact
Minoru Muramatsu--Head-Information Systems, Public Relations & Legal
Kenkichi Kosakai632007Director
Kouji Nakamura--Director
Yoshiaki Ishizaki--Director & Chief Compliance Officer
Takashi Kobayashi611980Director & Managing Executive Officer
Shigehiko Hattori752011Independent Director
Shigetaka Sato752013Independent Director
Shareholders
NameEquities%
Mitsubishi Chemical Holdings Corp. 316,320,000 56.3%
Nippon Life Insurance Co. 12,065,000 2.15%
Mitsubishi UFJ Financial Group, Inc. 9,372,113 1.67%
BlackRock Fund Advisors 4,780,800 0.85%
Mitsubishi Tanabe Pharma Employee Stock Ownership Plan 4,317,000 0.77%
The Vanguard Group, Inc. 3,995,307 0.71%
Nipro Corp. 3,821,000 0.68%
Tokio Marine Holdings, Inc. 3,132,900 0.56%
Norges Bank Investment Management 2,720,150 0.48%
Nomura Asset Management Co., Ltd. 2,285,223 0.41%
Holdings
NameEquities%Valuation
SUZUKEN CO., LTD. (9987) 1,548,1921.50%59,387,809 USD
Alfresa Holdings Corporation (2784) 2,225,8120.95%44,398,094 USD
Medipal Holdings Corp (7459) 2,123,6360.87%36,530,001 USD
VITAL KSK HOLDINGS INC (3151) 2,655,2964.34%21,736,572 USD
Nippon Shinyaku Co., Ltd. (4516) 519,0000.74%19,284,400 USD
T&D Holdings Inc (8795) 1,144,8800.17%15,278,366 USD
Mitsubishi Tanabe Pharma Corp (4508) 428,6000.076%7,450,821 USD
Nichi-iko Pharmaceutical Co., Ltd. (4541) 250,0000.41%6,027,620 USD
TSURUHA HOLDINGS INC. (3391) 40,0000.082%3,486,771 USD
Iyo Bank Ltd (8385) 291,5660.090%2,863,184 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
ALLERGAN PLC
SANOFI
BRISTOL-MYERS SQU..
NOVO NORDISK A/S
GLAXOSMITHKLINE P..
BAYER AG
ELI LILLY AND CO
ASTRAZENECA PLC
TEVA PHARMACEUTIC..
ABBOTT LABORATORI..
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
VALEANT PHARMACEU..
SHIRE PLC
MYLAN NV
Sector Pharmaceuticals
Mitsubishi Tanabe Pharma C : Connections
Mitsubishi Tanabe Pharma Factory Ltd.
The Kaiteki Institute, Inc.
The Osaka Chamber of Commerce & Industry
Meiji Yasuda Life Insurance Co.
Company contact information
Mitsubishi Tanabe Pharma Corp.
3-2-10 Dosho-machi
Chuo-Ku
Osaka 541-8505

Phone : +81.6.6205.5085
Fax : +81.6.6205.5262
Web : www.mt-pharma.co.jp
© 2016 People , Fundamentals and Ownership